Mirum Pharmaceuticals, Inc. (FRA:08D)

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $133.01M USD in the quarter ending September 30, 2025, with 47.17% growth. This brings the company's revenue in the last twelve months to $471.79M, up 53.66% year-over-year. In the year 2024, Mirum Pharmaceuticals had annual revenue of $336.89M with 80.76% growth.

• Revenue (ttm): $471.79M
• Revenue Growth: +53.66%
• P/S Ratio: 7.70
• Revenue / Employee: $1.47M
• Employees: 322
• Market Cap: 3.10B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	336.89M	150.51M	80.76%
Dec 31, 2023	186.37M	109.31M	141.85%
Dec 31, 2022	77.06M	57.92M	302.66%
Dec 31, 2021	19.14M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-